socalTECH

OCTOBER 1, 2013

Thousand Oaks-based Amgen reported this morning that it has completed its tender offer for Onyx Pharmaceuticals , and now expects its acquisition to complete today. billion net of estimated cash at Onyx. onyx pharmaceuticals amgen merger acquisition biotech lifescience cancer' Amgen said the deal is worth $9.7

Thousand Oaks 173

Thousand Oaks .Net Acquisition Report 173

socalTECH

AUGUST 26, 2013

Thousand Oaks-based biotech giant Amgen announced Sunday that it has acquired San Francisco biopharmaceuticals company Onyx Pharmaceuticals , in a deal worth $10.4 billion net of the estimated cash on hand at Onyx. billion net of the estimated cash on hand at Onyx. The deal is worth $9.7 The deal is worth $9.7

Thousand Oaks 153

Thousand Oaks .Net Acquisition Help 153

socalTECH

JANUARY 27, 2011

In a sign that Thousand Oaks-based Nexsan might be ramping up its IPO efforts again, after a delay last year, the firm filed an updated S-1 this week. The provider of data storage equipment reported that it had net income of $0.5M in net income of $19.28M in revenues for the three months ended September 30, 2010.

Thousand Oaks 147

Thousand Oaks .Net Report Marketing 147

socalTECH

JUNE 17, 2010

Inphi--which lists its headquarters as Sunnyvale, but has most of its operations in Westlake Village and Thousand Oaks--is looking to list on the NYSE and IPHI. In its S-1, the firm said it had net income of $7.3M In its S-1, the firm said it had net income of $7.3M on total revenues of $58.8M on total revenues of $58.8M

Westlake Village 133

Westlake Village Thousand Oaks Southern California .Net 133

socalTECH

MAY 23, 2011

Thousand Oaks-based Ceres , the developer of seeds aimed at producing renewable, biomass feedstocks for the biofuels industry, has filed for an IPO. The firm said it had a net loss of $22.5M According to a filing this morning by the firm, the company is aiming to raise up to $100M in an IPO on the NASDAQ Global Market as CERE.

Thousand Oaks 140

Thousand Oaks .Net Capital Marketing 140

socalTECH

AUGUST 26, 2019

Thousand Oaks-based Amgen announced this morning that it is acquiring Otezla , the anti-inflammatory drug used to treat psoriasis and psoriatic arthritis, which is currently owned by Celgene Corporation , in a deal worth $13.4 billion net of anticipated future cash tax benefits. billion in cash. Otezla had $1.6

Thousand Oaks 113

Thousand Oaks .Net Sales Acquisition 113

socalTECH

FEBRUARY 2, 2012

The firm reported net income of $1 billion on revenues of $3.7 Facebook filed for its IPO Wednesday afternoon, saying that it is looking to raise up to $5 billion, in what is expected to be the biggest IPO since Google. billion in 2011 in its S-1, which is being underwritten by Morgan Stanley, J.P. Morgan, Goldman Sachs & Co.,

Southern California 113

Southern California Thousand Oaks .Net Google 113